NCT03861000View on ClinicalTrials.gov

Title: Evaluation of a Novel PET Radioligand for Phosphodiesterase-4D (PDE4D)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 12, 2019

Primary Completion Date

February 11, 2020

Study Completion Date

February 11, 2020

Conditions
Depression
Interventions
DRUG

[C-11]T-1650

radio-labeled drug

DRUG

BPN14770

selective compound

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT03861000 - Title: Evaluation of a Novel PET Radioligand for Phosphodiesterase-4D (PDE4D) | Biotech Hunter | Biotech Hunter